# EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE
> **ANDA212362** · Abbreviated New Drug Application (Generic) · Sponsor: MSN LABS PVT LTD · Approved 2023-01-31
## Drug
- **FDA Application Number:** ANDA212362
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EMPAGLIFLOZIN METFORMIN HYDROCHLORIDE
- **Generic name:** Empagliflozin
- **Active ingredients:** EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MSN LABS PVT LTD
- **First approval:** 2023-01-31
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212362)
---
*AI Analytics · CC0 1.0*